Rnai Agent Targeting Marc1 Gene, And Use Thereof - EP4368717
The patent EP4368717 was granted to Olix Pharmaceuticals on May 15, 2024. The application was originally filed on Jul 8, 2022 under application number EP22838056A. The patent is currently recorded with a legal status of "Request For Examination Was Made".
EP4368717
- Application Number
- EP22838056A
- Filing Date
- Jul 8, 2022
- Status
- Request For Examination Was Made
- Apr 12, 2024
- Publication Date
- May 15, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents